NCT02354365

Brief Summary

Typically doctors adjust the settings on the ventilator to ensure that children receive enough help to decrease the work they perform to breathe, receive enough oxygen through the machine to pass into the blood and to the organs, and remove acid that builds up in the blood. However, sometimes the settings we choose can result in damage to the lungs. We are trying to find a better way to determine the best ventilator settings, which can minimize potential damage to the lungs, and still provide children with enough support to decrease the work they have to do to breathe. We believe we can personalize these choices for each child by looking at the pressure that is generated in the chest while children breathe with the ventilator. This is accomplished by using a small tube which goes through the nose and into the esophagus or stomach, which is hooked up to a computer or the ventilator to monitor pressure. This same tube can then also be used to monitor how much work children need to do to breathe as we are turning down the ventilator in preparation to remove the breathing tube.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
55

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2014

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

January 29, 2015

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 3, 2015

Completed
9.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

February 15, 2024

Status Verified

October 1, 2023

Enrollment Period

10.9 years

First QC Date

January 29, 2015

Last Update Submit

February 13, 2024

Conditions

Keywords

PEEP adjustmentTidal VolumeDriving PressureCompliance

Outcome Measures

Primary Outcomes (1)

  • Transpulmonary pressure

    Effect of cardiac index of increasing PEEP guided by transpulmonary pressure at PEEP.

    Two years

Secondary Outcomes (1)

  • Pressure rate product (PRP)

    Two years

Study Arms (3)

Normal lungs

Mechanically ventilated patients without pulmonary parenchymal disease or lower airway disease as measured by flow volume loops consistent with expiratory flow obstruction (e.g. seizures, apnea, upper airway obstruction).

Device: Transpulmonary Pressure measurement

Acute Hypoxic Respiratory Failure

Mechanically ventilated patients with two consecutive Saturation to FiO2 (SF) ratio \< 265 or PaO2 to FiO2 (PF) ratio \< 300 (e.g. pneumonia, ARDS).

Device: Transpulmonary Pressure measurement

Obstructive airway disease

Mechanically ventilated patients with flow volume loops consistent with expiratory flow obstruction (e.g. asthma, bronchiolitis).

Device: Transpulmonary Pressure measurement

Interventions

Transpulmonary pressure measurements are done by placing a catheter (often combined with a feeding tube) into the esophagus of a patient. Intermittently, the esophageal pressure is measured by inflating a small balloon on this catheter. The resulting esophageal pressure is accepted as representing the pleural pressure. The difference between this pressure and the airway pressure is the transpulmonary pressure and PEEP is raised or lowered to make this value zero so that the forces distending the alveoli are just balanced with the natural elasticity of the lung which wants to collapse the alveoli.

Acute Hypoxic Respiratory FailureNormal lungsObstructive airway disease

Eligibility Criteria

Age1 Week - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Any patient weighing \>2 kg between the ages of \> 37 weeks corrected gestational age and \<18 years who is intubated and mechanically ventilated in the pediatric intensive care unit at Children's Hospital Los Angeles will be eligible for the study.

You may qualify if:

  • We seek to group patients into 3 potential cohorts:
  • Normal Lungs (maximum 30 patients): Mechanically ventilated patients without pulmonary parenchymal disease or lower airway disease as measured by flow volume loops consistent with expiratory flow obstruction (e.g. seizures, apnea, upper airway obstruction).
  • AHRF (maximum 15 patients): Mechanically ventilated patients with two consecutive Saturation to FiO2 (SF) ratio \< 265 or PaO2 to FiO2 (PF) ratio \< 300 (e.g. pneumonia, ARDS).
  • Obstructive airway disease (15 patients): Mechanically ventilated patients with flow volume loops consistent with expiratory flow obstruction (e.g. asthma, bronchiolitis)

You may not qualify if:

  • Patients with a corrected gestational age of \< 37 weeks or above 18 years of age. Patients with esophageal pathology or inability to utilize an esophageal probe due to anatomy, those on a high frequency oscillator or jet ventilator and those with uncorrected or persistent cyanotic congenital heart diseases will be excluded. Also, patients with an endotracheal tube leak of more than 18% or inability to measure volume, pressure or flow at the endotracheal tube will be excluded from the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Hospital Los Angeles

Los Angeles, California, 90027, United States

Location

Related Publications (4)

  • Ingaramo OA, Ngo T, Khemani RG, Newth CJ. Impact of positive end-expiratory pressure on cardiac index measured by ultrasound cardiac output monitor*. Pediatr Crit Care Med. 2014 Jan;15(1):15-20. doi: 10.1097/PCC.0b013e3182976251.

    PMID: 24389709BACKGROUND
  • Ross PA, Khemani RG, Rubin SS, Bhalla AK, Newth CJ. Elevated positive end-expiratory pressure decreases cardiac index in a rhesus monkey model. Front Pediatr. 2014 Dec 3;2:134. doi: 10.3389/fped.2014.00134. eCollection 2014.

    PMID: 25520944BACKGROUND
  • Hotz JC, Sodetani CT, Van Steenbergen J, Khemani RG, Deakers TW, Newth CJ. Measurements Obtained From Esophageal Balloon Catheters Are Affected by the Esophageal Balloon Filling Volume in Children With ARDS. Respir Care. 2018 Feb;63(2):177-186. doi: 10.4187/respcare.05685. Epub 2017 Oct 31.

    PMID: 29089460BACKGROUND
  • Virk MK, Hotz JC, Wong W, Khemani RG, Newth CJL, Ross PA. Minimal Change in Cardiac Index With Increasing PEEP in Pediatric Acute Respiratory Distress Syndrome. Front Pediatr. 2019 Jan 29;7:9. doi: 10.3389/fped.2019.00009. eCollection 2019.

MeSH Terms

Conditions

Patient Compliance

Condition Hierarchy (Ancestors)

Patient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • Christopher Newth, MD

    Children's Hospital Los Angeles

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Week
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Pediatric Critical Care Medicine, Attending Physician

Study Record Dates

First Submitted

January 29, 2015

First Posted

February 3, 2015

Study Start

February 1, 2014

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

February 15, 2024

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will not share

Locations